
    
      The aim of this post market surveillance is to document the safety and efficacy of the
      drug-coated balloon SequentÂ® Please Neo in combination with the NSE Alpha scoring balloon in
      the treatment of both in-stent restenosis and de-novo lesions in native coronary arteries
      with reference diameters of 2.5 mm up to 4.0 mm with lesion lengths of 30 mm for procedural
      success and preservation of vessel patency
    
  